Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

NCT00335374 is registered in ClinicalTrials.gov with Solvay Pharmaceuticals as lead sponsor.

NCT NCT00335374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00335374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients
Lead sponsor
Solvay Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2007
Completion date
November 30, 2008
Enrollment
202 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

early stage parkinson's disease